Rivian Releases Third Quarter 2024 Financial Results
- Reaffirmed 2024 delivery outlook of 50,500 to 52,000 vehicles
- Secured R2 battery cell supply with multi-year LG Energy Solution contract
- Company on track for positive gross profit for fourth quarter 2024
- Launched R1 Tri-Motor configuration
The company remains on track for positive gross profit for the fourth quarter of 2024. This is expected to be driven primarily by improvements in revenue per unit, variable cost per unit, and fixed and semi-fixed costs per unit. The increase in revenue per unit is primarily due to an increase in the sale of regulatory credits and increased R1 average selling prices from an improvement in mix towards more premium variants. The variable and fixed / semi-fixed cost improvements are driven primarily by improvements in material cost and operational efficiencies in the production of R1 second generation vehicles.
RJ Scaringe, Rivian Founder and CEO, said:
“This quarter we have made progress against our key objectives and have seen meaningful progress on our Gen 2 R1 cost structure due to the new technologies incorporated into the vehicle and manufacturing process. We are excited about the future and our midsize SUV, R2, which we believe will be a fundamental driver of Rivian’s growth. We’re also looking forward to closing our proposed joint venture with
Today
This quarter
In August the company introduced Connect+, a streaming and connectivity service for
As previously disclosed on
Financial Highlights:
Revenues:
Total revenues for the third quarter of 2024 were
Gross Profit:
Cost of revenues for the third quarter of 2024 included
Operating Expenses and Operating Loss:
Total operating expenses in the third quarter of 2024 decreased to
In the third quarter of 2024, the company recognized a non-cash, stock-based compensation expense within operating expenses of
Net Loss:
Rivian’s net loss for the third quarter of 2024 was
Adjusted EBITDA (non-GAAP)*
Adjusted EBITDA* for the third quarter of 2024 was
Capital Expenditures:
Capital expenditures for the third quarter of 2024 were
Liquidity:
The third quarter of 2024’s ending cash, cash equivalents, and short-term investments balance of
For further information please see Rivian’s latest shareholder letter at www.rivian.com/investors.
The company will host an audio webcast to discuss its results and provide a business update at
Condensed Consolidated Balance Sheets |
||||||||
(in millions, except per share amounts) |
||||||||
(unaudited) |
||||||||
Assets |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
7,857 |
|
|
$ |
5,396 |
|
Short-term investments |
|
|
1,511 |
|
|
|
1,343 |
|
Accounts receivable, net |
|
|
161 |
|
|
|
217 |
|
Inventory |
|
|
2,620 |
|
|
|
2,680 |
|
Other current assets |
|
|
164 |
|
|
|
201 |
|
Total current assets |
|
|
12,313 |
|
|
|
9,837 |
|
Property, plant, and equipment, net |
|
|
3,874 |
|
|
|
3,819 |
|
Operating lease assets, net |
|
|
356 |
|
|
|
397 |
|
Other non-current assets |
|
|
235 |
|
|
|
209 |
|
Total assets |
|
$ |
16,778 |
|
|
$ |
14,262 |
|
|
|
|
|
|
||||
Liabilities and Stockholders’ Equity |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable |
|
$ |
981 |
|
|
$ |
617 |
|
Accrued liabilities |
|
|
1,145 |
|
|
|
887 |
|
Current portion of lease liabilities and other current liabilities |
|
|
361 |
|
|
|
429 |
|
Total current liabilities |
|
|
2,487 |
|
|
|
1,933 |
|
Long-term debt (includes |
|
|
4,431 |
|
|
|
5,468 |
|
Non-current lease liabilities |
|
|
324 |
|
|
|
361 |
|
Other non-current liabilities |
|
|
395 |
|
|
|
601 |
|
Total liabilities |
|
|
7,637 |
|
|
|
8,363 |
|
Commitments and contingencies |
|
|
|
|
||||
Stockholders' equity: |
|
|
|
|
||||
Preferred stock, |
|
|
— |
|
|
|
— |
|
Common stock, |
|
|
1 |
|
|
|
1 |
|
Additional paid-in capital |
|
|
27,695 |
|
|
|
28,455 |
|
Accumulated deficit |
|
|
(18,558 |
) |
|
|
(22,561 |
) |
Accumulated other comprehensive income |
|
|
3 |
|
|
|
4 |
|
Total stockholders' equity |
|
|
9,141 |
|
|
|
5,899 |
|
|
|
|
|
|
||||
Total liabilities and stockholders' equity |
|
$ |
16,778 |
|
|
$ |
14,262 |
|
Condensed Consolidated Statements of Operations |
||||||||||||||||
(in millions, except per share amounts) | ||||||||||||||||
(unaudited) | ||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
Revenues |
|
$ |
1,337 |
|
|
$ |
874 |
|
|
$ |
3,119 |
|
|
$ |
3,236 |
|
Cost of revenues |
|
|
1,814 |
|
|
|
1,266 |
|
|
|
4,543 |
|
|
|
4,606 |
|
Gross profit |
|
|
(477 |
) |
|
|
(392 |
) |
|
|
(1,424 |
) |
|
|
(1,370 |
) |
Operating expenses |
|
|
|
|
|
|
|
|
||||||||
Research and development |
|
|
529 |
|
|
|
350 |
|
|
|
1,469 |
|
|
|
1,239 |
|
Selling, general, and administrative |
|
|
434 |
|
|
|
427 |
|
|
|
1,265 |
|
|
|
1,419 |
|
Total operating expenses |
|
|
963 |
|
|
|
777 |
|
|
|
2,734 |
|
|
|
2,658 |
|
Loss from operations |
|
|
(1,440 |
) |
|
|
(1,169 |
) |
|
|
(4,158 |
) |
|
|
(4,028 |
) |
Interest income |
|
|
126 |
|
|
|
95 |
|
|
|
391 |
|
|
|
302 |
|
Interest expense |
|
|
(55 |
) |
|
|
(87 |
) |
|
|
(147 |
) |
|
|
(237 |
) |
Fair value gain (loss) on convertible note, net |
|
|
— |
|
|
|
60 |
|
|
|
— |
|
|
|
(30 |
) |
Other income (expense), net |
|
|
2 |
|
|
|
1 |
|
|
|
4 |
|
|
|
(8 |
) |
Loss before income taxes |
|
|
(1,367 |
) |
|
|
(1,100 |
) |
|
|
(3,910 |
) |
|
|
(4,001 |
) |
Provision for income taxes |
|
|
— |
|
|
|
— |
|
|
|
(1 |
) |
|
|
(2 |
) |
Net loss |
|
$ |
(1,367 |
) |
|
$ |
(1,100 |
) |
|
$ |
(3,911 |
) |
|
$ |
(4,003 |
) |
Net loss attributable to common stockholders, basic and diluted |
|
$ |
(1,367 |
) |
|
$ |
(1,100 |
) |
|
$ |
(3,911 |
) |
|
$ |
(4,003 |
) |
Net loss per share attributable to Class A and Class B common stockholders, basic and diluted |
|
$ |
(1.44 |
) |
|
$ |
(1.08 |
) |
|
$ |
(4.15 |
) |
|
$ |
(4.01 |
) |
Weighted-average common shares outstanding, basic and diluted |
|
|
952 |
|
|
|
1,014 |
|
|
|
942 |
|
|
|
998 |
|
Consolidated Statements of Cash Flows | ||||||||
(in millions) | ||||||||
(unaudited) | ||||||||
|
|
Nine Months Ended |
||||||
|
|
|
2023 |
|
|
|
2024 |
|
Cash flows from operating activities: |
|
|
|
|
||||
Net loss |
|
$ |
(3,911 |
) |
|
$ |
(4,003 |
) |
Depreciation and amortization |
|
|
667 |
|
|
|
813 |
|
Stock-based compensation expense |
|
|
606 |
|
|
|
538 |
|
Fair value loss on convertible note, net |
|
|
— |
|
|
|
30 |
|
Inventory LCNRV write-downs and losses on firm purchase commitments |
|
|
114 |
|
|
|
14 |
|
Other non-cash activities |
|
|
46 |
|
|
|
85 |
|
Changes in operating assets and liabilities: |
|
|
|
|
||||
Accounts receivable, net |
|
|
(135 |
) |
|
|
(57 |
) |
Inventory |
|
|
(1,471 |
) |
|
|
(208 |
) |
Other assets |
|
|
(129 |
) |
|
|
(41 |
) |
Accounts payable and accrued liabilities |
|
|
220 |
|
|
|
(339 |
) |
Other liabilities |
|
|
234 |
|
|
|
269 |
|
Net cash used in operating activities |
|
|
(3,759 |
) |
|
|
(2,899 |
) |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
|
||||
Purchases of short-term investments |
|
|
(1,405 |
) |
|
|
(2,476 |
) |
Maturities of short-term investments |
|
|
225 |
|
|
|
2,696 |
|
Capital expenditures |
|
|
(728 |
) |
|
|
(814 |
) |
Net cash used in investing activities |
|
|
(1,908 |
) |
|
|
(594 |
) |
|
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
|
||||
Proceeds from issuance of capital stock including employee stock purchase plan |
|
|
39 |
|
|
|
37 |
|
Proceeds from issuance of convertible notes |
|
|
1,485 |
|
|
|
1,000 |
|
Other financing activities |
|
|
(15 |
) |
|
|
(5 |
) |
Net cash provided by financing activities |
|
|
1,509 |
|
|
|
1,032 |
|
|
|
|
|
|
||||
Effect of exchange rate changes on cash and cash equivalents |
|
|
— |
|
|
|
— |
|
Net change in cash |
|
|
(4,158 |
) |
|
|
(2,461 |
) |
Cash, cash equivalents, and restricted cash—Beginning of period |
|
|
12,099 |
|
|
|
7,857 |
|
Cash, cash equivalents, and restricted cash—End of period |
|
$ |
7,941 |
|
|
$ |
5,396 |
|
|
|
|
|
|
||||
Supplemental disclosure of non-cash investing and financing activities: |
|
|
|
|
||||
Capital expenditures included in liabilities |
|
$ |
390 |
|
|
$ |
369 |
|
Capital stock issued to settle bonuses |
|
$ |
137 |
|
|
$ |
179 |
|
Right-of-use assets obtained in exchange for operating lease liabilities |
|
$ |
66 |
|
|
$ |
122 |
|
Reconciliation of Non-GAAP | ||||||||||||||||
Financial Measures | ||||||||||||||||
(in millions) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Adjusted EBITDA1 |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
Net loss |
|
$ |
(1,367 |
) |
|
$ |
(1,100 |
) |
|
$ |
(3,911 |
) |
|
$ |
(4,003 |
) |
Interest income, net |
|
|
(71 |
) |
|
|
(8 |
) |
|
|
(244 |
) |
|
|
(65 |
) |
Provision for income taxes |
|
|
— |
|
|
|
— |
|
|
|
1 |
|
|
|
2 |
|
Depreciation and amortization |
|
|
256 |
|
|
|
259 |
|
|
|
667 |
|
|
|
813 |
|
Stock-based compensation expense |
|
|
242 |
|
|
|
111 |
|
|
|
606 |
|
|
|
538 |
|
Other (income) expense, net |
|
|
(2 |
) |
|
|
(1 |
) |
|
|
(4 |
) |
|
|
8 |
|
Fair value (gain) loss on convertible note, net |
|
|
— |
|
|
|
(60 |
) |
|
|
— |
|
|
|
30 |
|
Cost of revenue efficiency initiatives |
|
|
15 |
|
|
|
37 |
|
|
|
35 |
|
|
|
193 |
|
Restructuring expenses |
|
|
— |
|
|
|
— |
|
|
|
42 |
|
|
|
30 |
|
Asset impairments and write-offs |
|
|
25 |
|
|
|
— |
|
|
|
25 |
|
|
|
30 |
|
Joint venture formation expenses and other items |
|
|
— |
|
|
|
5 |
|
|
|
— |
|
|
|
12 |
|
Adjusted EBITDA (non-GAAP) |
|
$ |
(902 |
) |
|
$ |
(757 |
) |
|
$ |
(2,783 |
) |
|
$ |
(2,412 |
) |
|
|
|
|
|
|
|
|
|
||||||||
1 The prior periods have been recast to conform to current period presentation. |
|
|
|
|
About
Learn more about the company, products, and careers at www.rivian.com.
Forward-Looking Statements:
This press release and statements that are made on our earnings call contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release and made on our earnings call that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our future operations, initiatives and business strategy, our cost reduction strategy and expectations regarding cost savings, our future financial results, vehicle profitability and future gross profits, our anticipated LCNRV charges, the planned use of our cash and cash equivalents, our future capital expenditures, the underlying trends in our business, our market opportunity, and our potential for growth, our production ramp and manufacturing capacity expansion and anticipated production levels, our expected future production and deliveries, our anticipated production and timing of launching the R2 platform in
*Non-GAAP Financial Measures
In addition to our results determined in accordance with generally accepted accounting principles in
Our non-GAAP financial measures include adjusted EBITDA defined as net loss before interest expense (income), net, provision for income taxes, depreciation and amortization, stock-based compensation, other (expense) income, net, and special items. Our management team ordinarily excludes special items from its review of the results of the ongoing operations. Special items is comprised of (i) cost of revenue efficiency initiatives which include costs incurred as we transition between major vehicle programs, cost incurred for negotiations with major suppliers regarding changing demand forecasts or design modifications, and other costs for enhancing capital and cost optimization of the Company (ii) restructuring expenses for significant actions taken by the Company, (iii) significant asset impairments and write-offs, and (iv) other items that we do not necessarily consider to be indicative of earnings from ongoing operating activities, including fair value gain or loss on convertible note, net, and joint venture formation expenses.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241107928108/en/
Investors:
ir@rivian.com
Media:
Source: